Vetropolycin 3.5g

List Price: ~~$14.99~~
Sale Price: $11.99

Code: Vetropo35

Enter pet & vet info at checkout

Let us contact your vet for you
Have your vet call or fax us
Mail us the original prescription

For the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Each gram contains Bacitracin Zinc 400 units, Neomycin Sulfate 5 mg (equivalent to 3.5 mg of Neomycin base), Polymyxin B Sulfate 10,000 units, in a base of White Petrolatum and Mineral Oil.

The three antibiotics present in Vetropolycin (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment provide a broad spectrum of activity against the gram-postitive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva.

Bacitracin

is effective against gram-postitive bacteria including hemolytic and non-hemolytic streptococci and staphylococi. Resistant strains rarely develop. Neomycin is effective against both gram-positive and gram-negative bacteria including staphylococci, Escherichia coli and Haemophilus influenzae and may strains of Proteus and Pseudomonas.

Polymyxin B

is bactericidal to gram-negative bacteria especially Pseudomonas. No resistant strains have been found to develop in vivo.

INDICATIONS:

In the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

PRECAUTIONS:

Sensitivity to Vetropolycin (bacitracinneomycin- polymyxin) veterinary ophthalmic ointment is rare; however, if a reaction occurs, discontinue use of the preparation. As with any antibiotic preparation, prolonged use may result in the overgrowth of non-susceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be re-evaluated.

Care should be taken not to contaminate the applicator tip of the tube during application of the preparation. Do not allow the applicator tip to come in contact with any tissue. ADVERSE REACTIONS: Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

DOSAGE AND ADMINISTRATION:

Apply a thin film over the cornea three or four times daily in dogs and cats. The area should be properly cleansed prior to the use of Vetropolycin (bacitracin-neomycin-polymyxin) veterinary ophthalmic ointment. Foreign bodies, crusted exudates, and debris should be carefully removed.

CAUTION:

Federal law restrict this drug to use by or on the order of a licensed veterinarian.

WARNING:

Do not use this product as a pre-surgical ocular lubricant. Adverse reactions of ocular irritation and corneal ulceration have been reported in association with such use.

HOW SUPPLIED:

3.5 g (1/8 Oz) sterile tamper proof tubes.

Some pets may be allergic to a component in Vetropolycin and may experience swelling, itching, and burning. Discontinue using Vetropolycin if this occurs. Long term use of Vetropolycin can cause fungal infections in your pet’s eyes.

Sensitivity to the ophthalmic ointment is rare, however, if a reaction occurs, discontinue use of the preparation. The prolonged use of antibiotic-containing preparations may result in overgrowth of non-susceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in two or three days, the diagnosis and therapy should be reevaluated. Animals under treatment with this product should be observed for usual signs of corticosteroid overdose which include polydipsia, polyuria and occasionally an increase in weight. Use of corticosteroids, depending on dose, duration, and specific steroid, may result in inhibition of endogenous steroid production following drug withdrawal. In patients presently receiving or recently withdrawn from systemic corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in unusually stressful situations. Care should be taken not to contaminate the applicator tip during administration of the preparation.